David P. Schenkein - 19 Oct 2022 Form 3 Insider Report for Prime Medicine, Inc. (PRME)

Role: Director
Signature: /s/ Carman Alenson attorney-in-fact
Issuer symbol: PRME
Transactions as of: 19 Oct 2022
Net transactions value: $0
Form type: 3
Filing time: 19 Oct 2022, 20:09:05 UTC
Previous filing: 23 Jun 2022
Next filing: 19 Jan 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney